share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰製藥 | 4：持股變動聲明-董事 SACHS BRUCE I
美股sec公告 ·  08/02 16:17
Moomoo AI 已提取核心訊息
On August 1, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a significant transaction involving the company's common stock. Sachs executed a sale of 5,295 shares at a price of $508.00 per share, resulting in a total transaction value of $2,689,860. This sale followed an acquisition of the same number of shares through the exercise of derivative securities at a price of $125.71 per share. After these transactions, Sachs's direct holdings in Vertex Pharmaceuticals totaled 40,000 shares of common stock.
On August 1, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a significant transaction involving the company's common stock. Sachs executed a sale of 5,295 shares at a price of $508.00 per share, resulting in a total transaction value of $2,689,860. This sale followed an acquisition of the same number of shares through the exercise of derivative securities at a price of $125.71 per share. After these transactions, Sachs's direct holdings in Vertex Pharmaceuticals totaled 40,000 shares of common stock.
2024年8月1日，與福泰製藥公司（VRTX）有關的布魯斯·艾·薩克斯（Bruce I. Sachs）完成了一項涉及該公司普通股的重大交易。薩克斯以每股508.00美元的價格出售了5,295股股票，交易總價值爲2,689,860美元。此次出售在以每股125.71美元的價格行使衍生證券獲得相同數量的股票之後進行。在這些交易之後，薩克斯在福泰製藥擁有40,000股普通股。
2024年8月1日，與福泰製藥公司（VRTX）有關的布魯斯·艾·薩克斯（Bruce I. Sachs）完成了一項涉及該公司普通股的重大交易。薩克斯以每股508.00美元的價格出售了5,295股股票，交易總價值爲2,689,860美元。此次出售在以每股125.71美元的價格行使衍生證券獲得相同數量的股票之後進行。在這些交易之後，薩克斯在福泰製藥擁有40,000股普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息